Featured Article

Call to Action Issued to Address Ongoing Osteoporosis Treatment Crisis

Call to Action Issued to Address Ongoing Osteoporosis Treatment Crisis

Kenneth Saag, MD, president of the National Osteoporosis Foundation (NOF), co-chair of the National Bone Health Alliance, and Rheumatology Advisor advisory board member, reports on the recent changes that have led to the current state of osteoporosis treatment in the US.

Latest News

Sarcopenic Obesity in Osteoarthritis vs Rheumatoid Arthritis

Sarcopenic Obesity in Osteoarthritis vs Rheumatoid Arthritis

Individuals with osteoarthritis may exhibit a higher prevalence of sarcopenic obesity, compared with patients with rheumatoid arthritis.

USPSTF Updates Osteoporosis Screening Recommendations for Fracture Prevention

USPSTF Updates Osteoporosis Screening Recommendations for Fracture Prevention

All women 65, high-risk postmenopausal women 65 should undergo bone measurement testing.

Bone Strength, BMD Assessment Cost-Effective for Postmenopausal Osteoporosis Screening

Bone Strength, BMD Assessment Cost-Effective for Postmenopausal Osteoporosis Screening

In postmenopausal women, assessment of bone strength and BMD is a cost-effective strategy of screening for osteoporosis.

Romosozumab Decreases Fracture Risk in Women With Osteoporosis Taking Alendronate

Romosozumab Decreases Fracture Risk in Women With Osteoporosis Taking Alendronate

In postmenopausal women at high risk for fracture, treatment with romosozumab for 12 months, followed by alendronate, was associated with significantly fewer hip fractures than treatment with alendronate alone.

Femoral Neck Bone Loss in Males Protected by High Dietary Fiber

Femoral Neck Bone Loss in Males Protected by High Dietary Fiber

Higher dietary fiber and fruit fiber is protective against bone loss at the femoral neck in men.

Vertebral Fracture Assessment vs Conventional Spine Radiography

Vertebral Fracture Assessment vs Conventional Spine Radiography

The use of vertebral fracture assessment has shown adequate performance for the detection of vertebral fractures.

Zoledronate Shows Prolonged Antiresorptive Activity in Postmenopausal Women With Osteopenia

Zoledronate Shows Prolonged Antiresorptive Activity in Postmenopausal Women With Osteopenia

Prolonged antiresorptive activity of ≥3 years has been associated with single zoledronate doses between 1 and 5 mg in postmenopausal women with osteopenia.

Incidence of New Fractures Reduced With Abaloparatide Followed by Alendronate

Incidence of New Fractures Reduced With Abaloparatide Followed by Alendronate

Tymlos is approved to treat postmenopausal women with osteoporosis at high risk for fracture.

Incident Radiographic Vertebral Fractures Associated with Back Pain in Older Men

Incident Radiographic Vertebral Fractures Associated with Back Pain in Older Men

Clinically undiagnossed radiographic VFs are linked to increased back pain symptoms.

Osteoporotic Fractures, Diabetes Complications Similarly Affect QoL

Osteoporotic Fractures, Diabetes Complications Similarly Affect QoL

Quality of life is similarly impacted by osteoporotic fractures and complications of diabetes.

Sign Up for Free e-newsletters